Burkly Linda
EVP, Chief Scientific Officer
1 company
Insider Signal Score
50
AverageTrades Analyzed
6
12M Win Rate
33.3%
Avg 3M Return
+2.4%
Avg 12M Return
-11.4%
Burkly Linda is an EVP, Chief Scientific Officer at Editas Medicine, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $172K based on current market prices.
Holdings by Company
EDITJul 28, 2026
Current Shares62.4K
Value$171.5K
Net Activity-26,975
Bought: 0Sold: 27.0K
Transaction History
Showing 7 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 4,928 | $2.67 | $13,157.76 | -7.3% | - | - | |
| Dec 3, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 713 | $2.15 | $1,535.16 | -1.0% | -13.7% | - | |
| Sep 3, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 710 | $2.60 | $1,843.23 | -1.0% | -15.6% | - | |
| Jul 31, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 5,121 | $2.49 | $12,756.92 | -7.4% | +21.1% | +2.8% | |
| Jun 3, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 726 | $1.72 | $1,251.84 | -1.0% | +35.7% | +52.7% | |
| Mar 4, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 2,891 | $1.71 | $4,945.63 | -4.0% | +0.6% | +25.0% | |
| Jul 25, 2024 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 11,886 | $5.42 | $64,369.82 | -14.0% | -42.4% | -43.4% |